TrialJectory
Turk K. is a seasoned professional in the healthcare and pharmaceutical industries, currently serving as an Advisory Board Member and Strategic Business Development Executive at cliexa since March 2024, and as the Head of Leal Health Turkey since December 2022. With extensive experience in oncology and clinical development, Turk has held significant positions, including Cancer Research Physician at BBROS GROUP, Strategy & Research Lead at ADC Therapeutics, and Head of Clinical Development & Medical Affairs at Oncolys BioPharma Inc. Educational qualifications include a PhD in Clinical Pharmacology from Istanbul University and a Medical Doctor degree from Cukurova University. Turk has a strong background in managing oncology medical affairs and clinical strategies, with a focus on various cancer types and therapeutic areas, contributing to advancements in immuno-oncology and patient-centered care.
This person is not in any teams
This person is not in any offices
TrialJectory
1 followers
TrialJectory is a patient-first digital health company with a mission to democratize access to advanced cancer treatment. We use artificial intelligence (AI) to empower patients to own their cancer journey and analyze our global patient community's real-world data to empower cancer patients to make the most informed decisions about their care.